nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.114	0.181	CbGbCtD
Mexiletine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0996	0.158	CbGbCtD
Mexiletine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.072	0.114	CbGbCtD
Mexiletine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0576	0.0912	CbGbCtD
Mexiletine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0489	0.0774	CbGbCtD
Mexiletine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0487	0.0771	CbGbCtD
Mexiletine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0377	0.0598	CbGbCtD
Mexiletine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0351	0.0556	CbGbCtD
Mexiletine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0328	0.0519	CbGbCtD
Mexiletine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0282	0.0446	CbGbCtD
Mexiletine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0161	0.0255	CbGbCtD
Mexiletine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0158	0.0251	CbGbCtD
Mexiletine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0148	0.0234	CbGbCtD
Mexiletine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0101	0.0159	CbGbCtD
Mexiletine—SCN5A—Cardiac Progenitor Differentiation—LIN28B—peripheral nervous system neoplasm	0.00354	0.0739	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.00287	0.0598	CbGpPWpGaD
Mexiletine—SCN9A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00186	0.0387	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.00179	0.0374	CbGpPWpGaD
Mexiletine—SCN2A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00171	0.0356	CbGpPWpGaD
Mexiletine—SCN4A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00171	0.0356	CbGpPWpGaD
Mexiletine—SCN10A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00164	0.0343	CbGpPWpGaD
Mexiletine—SCN5A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00116	0.0241	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00113	0.0236	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.00111	0.0231	CbGpPWpGaD
Mexiletine—SCN5A—Cardiac Progenitor Differentiation—NCAM1—peripheral nervous system neoplasm	0.000908	0.0189	CbGpPWpGaD
Mexiletine—SCN9A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000906	0.0189	CbGpPWpGaD
Mexiletine—SCN4A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000833	0.0174	CbGpPWpGaD
Mexiletine—SCN2A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000833	0.0174	CbGpPWpGaD
Mexiletine—SCN10A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000803	0.0168	CbGpPWpGaD
Mexiletine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000801	0.0167	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.0008	0.0167	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000716	0.0149	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000701	0.0146	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.000647	0.0135	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000645	0.0134	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000645	0.0134	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000622	0.013	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.000603	0.0126	CbGpPWpGaD
Mexiletine—AHR—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000583	0.0122	CbGpPWpGaD
Mexiletine—SCN5A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000565	0.0118	CbGpPWpGaD
Mexiletine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000524	0.0109	CbGpPWpGaD
Mexiletine—AHR—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000519	0.0108	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000501	0.0104	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.000474	0.00988	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00046	0.0096	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00046	0.0096	CbGpPWpGaD
Mexiletine—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000444	0.00927	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000444	0.00925	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000437	0.00912	CbGpPWpGaD
Mexiletine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000397	0.00124	CcSEcCtD
Mexiletine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000396	0.00123	CcSEcCtD
Mexiletine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000394	0.00123	CcSEcCtD
Mexiletine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000392	0.00122	CcSEcCtD
Mexiletine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000391	0.00122	CcSEcCtD
Mexiletine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000391	0.00122	CcSEcCtD
Mexiletine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00039	0.00122	CcSEcCtD
Mexiletine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00039	0.00122	CcSEcCtD
Mexiletine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000387	0.00121	CcSEcCtD
Mexiletine—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.00121	CcSEcCtD
Mexiletine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000387	0.00121	CcSEcCtD
Mexiletine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000386	0.00121	CcSEcCtD
Mexiletine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000386	0.0012	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000386	0.0012	CcSEcCtD
Mexiletine—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.0012	CcSEcCtD
Mexiletine—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.0012	CcSEcCtD
Mexiletine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000383	0.0012	CcSEcCtD
Mexiletine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000383	0.0012	CcSEcCtD
Mexiletine—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.00038	0.00793	CbGpPWpGaD
Mexiletine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00038	0.00119	CcSEcCtD
Mexiletine—Malaise—Etoposide—peripheral nervous system neoplasm	0.000379	0.00118	CcSEcCtD
Mexiletine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000379	0.00118	CcSEcCtD
Mexiletine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000376	0.00117	CcSEcCtD
Mexiletine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000376	0.00117	CcSEcCtD
Mexiletine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000376	0.00117	CcSEcCtD
Mexiletine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000375	0.00117	CcSEcCtD
Mexiletine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000375	0.00117	CcSEcCtD
Mexiletine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000374	0.00117	CcSEcCtD
Mexiletine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000372	0.00116	CcSEcCtD
Mexiletine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000369	0.00115	CcSEcCtD
Mexiletine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000369	0.00115	CcSEcCtD
Mexiletine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000369	0.00115	CcSEcCtD
Mexiletine—Rash—Topotecan—peripheral nervous system neoplasm	0.000368	0.00115	CcSEcCtD
Mexiletine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000368	0.00115	CcSEcCtD
Mexiletine—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000368	0.00115	CcSEcCtD
Mexiletine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000367	0.00114	CcSEcCtD
Mexiletine—Headache—Topotecan—peripheral nervous system neoplasm	0.000366	0.00114	CcSEcCtD
Mexiletine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000366	0.00114	CcSEcCtD
Mexiletine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000366	0.00114	CcSEcCtD
Mexiletine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000365	0.00114	CcSEcCtD
Mexiletine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000365	0.00114	CcSEcCtD
Mexiletine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000365	0.00114	CcSEcCtD
Mexiletine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000364	0.00114	CcSEcCtD
Mexiletine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000364	0.00113	CcSEcCtD
Mexiletine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000363	0.00113	CcSEcCtD
Mexiletine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000363	0.00113	CcSEcCtD
Mexiletine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000363	0.00113	CcSEcCtD
Mexiletine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000362	0.00756	CbGpPWpGaD
Mexiletine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000362	0.00113	CcSEcCtD
Mexiletine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000362	0.00113	CcSEcCtD
Mexiletine—Pain—Vincristine—peripheral nervous system neoplasm	0.000362	0.00113	CcSEcCtD
Mexiletine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000362	0.00113	CcSEcCtD
Mexiletine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000361	0.00113	CcSEcCtD
Mexiletine—Rash—Melphalan—peripheral nervous system neoplasm	0.000361	0.00113	CcSEcCtD
Mexiletine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00036	0.00112	CcSEcCtD
Mexiletine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000359	0.00112	CcSEcCtD
Mexiletine—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000358	0.00112	CcSEcCtD
Mexiletine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000358	0.00112	CcSEcCtD
Mexiletine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000355	0.0074	CbGpPWpGaD
Mexiletine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000353	0.0011	CcSEcCtD
Mexiletine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00035	0.00109	CcSEcCtD
Mexiletine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000349	0.00109	CcSEcCtD
Mexiletine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000347	0.00108	CcSEcCtD
Mexiletine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000347	0.00108	CcSEcCtD
Mexiletine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000347	0.00108	CcSEcCtD
Mexiletine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000346	0.00108	CcSEcCtD
Mexiletine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000346	0.00108	CcSEcCtD
Mexiletine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000344	0.00107	CcSEcCtD
Mexiletine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000344	0.00107	CcSEcCtD
Mexiletine—SCN9A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000343	0.00715	CbGpPWpGaD
Mexiletine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000341	0.00106	CcSEcCtD
Mexiletine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.00106	CcSEcCtD
Mexiletine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00034	0.00106	CcSEcCtD
Mexiletine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00034	0.00106	CcSEcCtD
Mexiletine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000338	0.00105	CcSEcCtD
Mexiletine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000336	0.00105	CcSEcCtD
Mexiletine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000336	0.00105	CcSEcCtD
Mexiletine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000335	0.00104	CcSEcCtD
Mexiletine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000335	0.00104	CcSEcCtD
Mexiletine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.00104	CcSEcCtD
Mexiletine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000334	0.00104	CcSEcCtD
Mexiletine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.00103	CcSEcCtD
Mexiletine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000332	0.00103	CcSEcCtD
Mexiletine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000331	0.00103	CcSEcCtD
Mexiletine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000329	0.00103	CcSEcCtD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000326	0.00679	CbGpPWpGaD
Mexiletine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000324	0.00101	CcSEcCtD
Mexiletine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000324	0.00101	CcSEcCtD
Mexiletine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00032	0.000999	CcSEcCtD
Mexiletine—Pain—Cisplatin—peripheral nervous system neoplasm	0.00032	0.000998	CcSEcCtD
Mexiletine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000986	CcSEcCtD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.000316	0.00659	CbGpPWpGaD
Mexiletine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000315	0.000983	CcSEcCtD
Mexiletine—SCN4A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000315	0.00657	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000315	0.00657	CbGpPWpGaD
Mexiletine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000975	CcSEcCtD
Mexiletine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000312	0.000973	CcSEcCtD
Mexiletine—SCN5A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000312	0.00651	CbGpPWpGaD
Mexiletine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000308	0.000962	CcSEcCtD
Mexiletine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000308	0.00096	CcSEcCtD
Mexiletine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000956	CcSEcCtD
Mexiletine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000306	0.000954	CcSEcCtD
Mexiletine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000305	0.000951	CcSEcCtD
Mexiletine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.00095	CcSEcCtD
Mexiletine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000304	0.000947	CcSEcCtD
Mexiletine—SCN10A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000304	0.00633	CbGpPWpGaD
Mexiletine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000301	0.00094	CcSEcCtD
Mexiletine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000301	0.00094	CcSEcCtD
Mexiletine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000301	0.000937	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000932	CcSEcCtD
Mexiletine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000299	0.000932	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000298	0.00623	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000298	0.00622	CbGpPWpGaD
Mexiletine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000296	0.000923	CcSEcCtD
Mexiletine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000296	0.000922	CcSEcCtD
Mexiletine—Pain—Etoposide—peripheral nervous system neoplasm	0.000293	0.000915	CcSEcCtD
Mexiletine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000293	0.000915	CcSEcCtD
Mexiletine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000912	CcSEcCtD
Mexiletine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000291	0.000906	CcSEcCtD
Mexiletine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00029	0.000903	CcSEcCtD
Mexiletine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000287	0.00598	CbGpPWpGaD
Mexiletine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000283	0.000881	CcSEcCtD
Mexiletine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000281	0.000878	CcSEcCtD
Mexiletine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000877	CcSEcCtD
Mexiletine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00028	0.000875	CcSEcCtD
Mexiletine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00028	0.000873	CcSEcCtD
Mexiletine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000279	0.000871	CcSEcCtD
Mexiletine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.00087	CcSEcCtD
Mexiletine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000277	0.000864	CcSEcCtD
Mexiletine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000277	0.000863	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000862	CcSEcCtD
Mexiletine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000276	0.00086	CcSEcCtD
Mexiletine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000859	CcSEcCtD
Mexiletine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000275	0.000858	CcSEcCtD
Mexiletine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000271	0.000845	CcSEcCtD
Mexiletine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000271	0.000845	CcSEcCtD
Mexiletine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000844	CcSEcCtD
Mexiletine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000269	0.00084	CcSEcCtD
Mexiletine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000269	0.000839	CcSEcCtD
Mexiletine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000269	0.000838	CcSEcCtD
Mexiletine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000838	CcSEcCtD
Mexiletine—Rash—Vincristine—peripheral nervous system neoplasm	0.000267	0.000832	CcSEcCtD
Mexiletine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000267	0.000832	CcSEcCtD
Mexiletine—Headache—Vincristine—peripheral nervous system neoplasm	0.000265	0.000827	CcSEcCtD
Mexiletine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000261	0.000814	CcSEcCtD
Mexiletine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000813	CcSEcCtD
Mexiletine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000812	CcSEcCtD
Mexiletine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000256	0.000799	CcSEcCtD
Mexiletine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000798	CcSEcCtD
Mexiletine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000795	CcSEcCtD
Mexiletine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000253	0.000788	CcSEcCtD
Mexiletine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000787	CcSEcCtD
Mexiletine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000251	0.000784	CcSEcCtD
Mexiletine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000781	CcSEcCtD
Mexiletine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000777	CcSEcCtD
Mexiletine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000775	CcSEcCtD
Mexiletine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000246	0.000767	CcSEcCtD
Mexiletine—SCN9A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000244	0.0051	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000243	0.00507	CbGpPWpGaD
Mexiletine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000754	CcSEcCtD
Mexiletine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000752	CcSEcCtD
Mexiletine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000746	CcSEcCtD
Mexiletine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000238	0.000742	CcSEcCtD
Mexiletine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000738	CcSEcCtD
Mexiletine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000236	0.000736	CcSEcCtD
Mexiletine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000236	0.000735	CcSEcCtD
Mexiletine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000235	0.000732	CcSEcCtD
Mexiletine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000728	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000233	0.00486	CbGpPWpGaD
Mexiletine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000721	CcSEcCtD
Mexiletine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000719	CcSEcCtD
Mexiletine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000713	CcSEcCtD
Mexiletine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000227	0.000707	CcSEcCtD
Mexiletine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000706	CcSEcCtD
Mexiletine—SCN2A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000225	0.00469	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000225	0.00469	CbGpPWpGaD
Mexiletine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000697	CcSEcCtD
Mexiletine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000222	0.000693	CcSEcCtD
Mexiletine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000692	CcSEcCtD
Mexiletine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.00069	CcSEcCtD
Mexiletine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000682	CcSEcCtD
Mexiletine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000218	0.00068	CcSEcCtD
Mexiletine—SCN10A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000217	0.00452	CbGpPWpGaD
Mexiletine—Rash—Etoposide—peripheral nervous system neoplasm	0.000216	0.000674	CcSEcCtD
Mexiletine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000216	0.000674	CcSEcCtD
Mexiletine—Headache—Etoposide—peripheral nervous system neoplasm	0.000215	0.00067	CcSEcCtD
Mexiletine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000667	CcSEcCtD
Mexiletine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000666	CcSEcCtD
Mexiletine—SCN5A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000213	0.00445	CbGpPWpGaD
Mexiletine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000213	0.00445	CbGpPWpGaD
Mexiletine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000662	CcSEcCtD
Mexiletine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.00066	CcSEcCtD
Mexiletine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000659	CcSEcCtD
Mexiletine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000658	CcSEcCtD
Mexiletine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000653	CcSEcCtD
Mexiletine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000649	CcSEcCtD
Mexiletine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000646	CcSEcCtD
Mexiletine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000641	CcSEcCtD
Mexiletine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000636	CcSEcCtD
Mexiletine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000204	0.000635	CcSEcCtD
Mexiletine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000634	CcSEcCtD
Mexiletine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000631	CcSEcCtD
Mexiletine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000625	CcSEcCtD
Mexiletine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000625	CcSEcCtD
Mexiletine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000618	CcSEcCtD
Mexiletine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000613	CcSEcCtD
Mexiletine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000612	CcSEcCtD
Mexiletine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.00061	CcSEcCtD
Mexiletine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000608	CcSEcCtD
Mexiletine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000604	CcSEcCtD
Mexiletine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000601	CcSEcCtD
Mexiletine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000192	0.0006	CcSEcCtD
Mexiletine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000597	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000191	0.00399	CbGpPWpGaD
Mexiletine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000189	0.00059	CcSEcCtD
Mexiletine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000589	CcSEcCtD
Mexiletine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000587	CcSEcCtD
Mexiletine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000587	CcSEcCtD
Mexiletine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00058	CcSEcCtD
Mexiletine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000579	CcSEcCtD
Mexiletine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000579	CcSEcCtD
Mexiletine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000572	CcSEcCtD
Mexiletine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000566	CcSEcCtD
Mexiletine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00018	0.00056	CcSEcCtD
Mexiletine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000559	CcSEcCtD
Mexiletine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000555	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000546	CcSEcCtD
Mexiletine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000546	CcSEcCtD
Mexiletine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000543	CcSEcCtD
Mexiletine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000173	0.00361	CbGpPWpGaD
Mexiletine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000538	CcSEcCtD
Mexiletine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000536	CcSEcCtD
Mexiletine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000534	CcSEcCtD
Mexiletine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000533	CcSEcCtD
Mexiletine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000528	CcSEcCtD
Mexiletine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000518	CcSEcCtD
Mexiletine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000517	CcSEcCtD
Mexiletine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000165	0.00343	CbGpPWpGaD
Mexiletine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000513	CcSEcCtD
Mexiletine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000513	CcSEcCtD
Mexiletine—SCN9A—Axon guidance—MET—peripheral nervous system neoplasm	0.000164	0.00342	CbGpPWpGaD
Mexiletine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000505	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000162	0.00337	CbGpPWpGaD
Mexiletine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000498	CcSEcCtD
Mexiletine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000495	CcSEcCtD
Mexiletine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000494	CcSEcCtD
Mexiletine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000493	CcSEcCtD
Mexiletine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000157	0.00049	CcSEcCtD
Mexiletine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000488	CcSEcCtD
Mexiletine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000478	CcSEcCtD
Mexiletine—SCN5A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000152	0.00318	CbGpPWpGaD
Mexiletine—AHR—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000152	0.00318	CbGpPWpGaD
Mexiletine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000474	CcSEcCtD
Mexiletine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000474	CcSEcCtD
Mexiletine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000474	CcSEcCtD
Mexiletine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000474	CcSEcCtD
Mexiletine—SCN9A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000151	0.00316	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—MET—peripheral nervous system neoplasm	0.00015	0.00314	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—MET—peripheral nervous system neoplasm	0.00015	0.00314	CbGpPWpGaD
Mexiletine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000457	CcSEcCtD
Mexiletine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000454	CcSEcCtD
Mexiletine—SCN10A—Axon guidance—MET—peripheral nervous system neoplasm	0.000145	0.00303	CbGpPWpGaD
Mexiletine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000442	CcSEcCtD
Mexiletine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000439	CcSEcCtD
Mexiletine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000439	CcSEcCtD
Mexiletine—SCN4A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000139	0.0029	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000139	0.0029	CbGpPWpGaD
Mexiletine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000138	0.00043	CcSEcCtD
Mexiletine—SCN10A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000134	0.0028	CbGpPWpGaD
Mexiletine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000132	0.00041	CcSEcCtD
Mexiletine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000409	CcSEcCtD
Mexiletine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000398	CcSEcCtD
Mexiletine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000396	CcSEcCtD
Mexiletine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000381	CcSEcCtD
Mexiletine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.00038	CcSEcCtD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000121	0.00253	CbGpPWpGaD
Mexiletine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000378	CcSEcCtD
Mexiletine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000378	CcSEcCtD
Mexiletine—Headache—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000376	CcSEcCtD
Mexiletine—SCN9A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00012	0.0025	CbGpPWpGaD
Mexiletine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000367	CcSEcCtD
Mexiletine—SCN9A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000117	0.00244	CbGpPWpGaD
Mexiletine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000356	CcSEcCtD
Mexiletine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000353	CcSEcCtD
Mexiletine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.00035	CcSEcCtD
Mexiletine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000349	CcSEcCtD
Mexiletine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000348	CcSEcCtD
Mexiletine—SCN2A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00011	0.00229	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00011	0.00229	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000108	0.00225	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000107	0.00224	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000107	0.00224	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000106	0.00221	CbGpPWpGaD
Mexiletine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000329	CcSEcCtD
Mexiletine—SCN10A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000104	0.00216	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—MET—peripheral nervous system neoplasm	0.000102	0.00213	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	9.93e-05	0.00207	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	9.93e-05	0.00207	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	9.57e-05	0.002	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—PTPN11—peripheral nervous system neoplasm	9.43e-05	0.00197	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—NRAS—peripheral nervous system neoplasm	9.1e-05	0.0019	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.99e-05	0.00188	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.81e-05	0.00184	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	8.54e-05	0.00178	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—NRAS—peripheral nervous system neoplasm	8.37e-05	0.00175	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—NRAS—peripheral nervous system neoplasm	8.37e-05	0.00175	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—NRAS—peripheral nervous system neoplasm	8.07e-05	0.00168	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	8.03e-05	0.00168	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	7.85e-05	0.00164	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	7.85e-05	0.00164	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	7.57e-05	0.00158	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—ERBB2—peripheral nervous system neoplasm	7.45e-05	0.00156	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MET—peripheral nervous system neoplasm	7.28e-05	0.00152	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	7.13e-05	0.00149	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	6.73e-05	0.0014	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—HRAS—peripheral nervous system neoplasm	6.66e-05	0.00139	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	6.64e-05	0.00139	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—NRAS—peripheral nervous system neoplasm	6.5e-05	0.00136	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.25e-05	0.0013	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—HRAS—peripheral nervous system neoplasm	6.12e-05	0.00128	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—HRAS—peripheral nervous system neoplasm	6.12e-05	0.00128	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.08e-05	0.00127	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—NRAS—peripheral nervous system neoplasm	5.97e-05	0.00125	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—NRAS—peripheral nervous system neoplasm	5.97e-05	0.00125	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.95e-05	0.00124	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—HRAS—peripheral nervous system neoplasm	5.9e-05	0.00123	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—NRAS—peripheral nervous system neoplasm	5.76e-05	0.0012	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—NRAS—peripheral nervous system neoplasm	5.67e-05	0.00118	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	5.32e-05	0.00111	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.3e-05	0.0011	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	5.22e-05	0.00109	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.75e-05	0.000992	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	4.39e-05	0.000916	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.37e-05	0.000911	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.37e-05	0.000911	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	4.3e-05	0.000898	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.22e-05	0.000881	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	4.21e-05	0.000879	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.21e-05	0.000879	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—AKT1—peripheral nervous system neoplasm	4.2e-05	0.000876	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	4.15e-05	0.000866	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	4.12e-05	0.000861	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.09e-05	0.000853	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	4.05e-05	0.000846	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	4.05e-05	0.000844	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	3.97e-05	0.000828	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.86e-05	0.000805	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.86e-05	0.000805	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.72e-05	0.000776	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.58e-05	0.000746	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	3.05e-05	0.000637	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.97e-05	0.00062	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	2.96e-05	0.000618	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	2.93e-05	0.000611	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	2.82e-05	0.000588	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.76e-05	0.000576	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	2.66e-05	0.000555	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.61e-05	0.000545	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	2.61e-05	0.000544	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	2.59e-05	0.00054	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	2.48e-05	0.000517	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	2.39e-05	0.000498	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	2.25e-05	0.000469	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	2.2e-05	0.00046	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.15e-05	0.000448	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	2.11e-05	0.000441	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.1e-05	0.000438	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	2.07e-05	0.000432	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	2e-05	0.000416	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.91e-05	0.000399	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.85e-05	0.000386	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.84e-05	0.000384	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	1.73e-05	0.00036	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.69e-05	0.000353	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	1.69e-05	0.000353	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.66e-05	0.000346	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.57e-05	0.000327	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.56e-05	0.000326	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.49e-05	0.000311	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.47e-05	0.000307	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.32e-05	0.000276	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.26e-05	0.000264	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.24e-05	0.00026	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.21e-05	0.000252	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.2e-05	0.00025	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.18e-05	0.000246	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.02e-05	0.000213	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.02e-05	0.000212	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	9.97e-06	0.000208	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.75e-06	0.000203	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	9.61e-06	0.0002	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	7.84e-06	0.000164	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	7.7e-06	0.000161	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	4.66e-06	9.72e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	4.56e-06	9.52e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	3.24e-06	6.76e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.74e-06	5.72e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.12e-06	4.42e-05	CbGpPWpGaD
